Recurrent Verrucous Carcinoma of the Larynx Recruiting Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0029506 (Recurrent Verrucous Carcinoma of the Larynx)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs